Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged pharmaceuticals · clear
The competitive landscape of ANDA litigation has played a significant role in shaping the pharmaceutical industry, showcasing the legal experts who make a substantial impact in this field. Attorneys specializing in ANDA cases are pivotal in protecting the…
In the pharmaceutical industry, innovation drives progress, but intense legal battles, particularly in ANDA (Abbreviated New Drug Application) litigation, shape the competitive landscape. Our recently released 2024 ANDA Litigation Intelligence Report…
Written by : Rhett D. Ramsey & Joseph Mallon, Ph.D. Judge Andrews of the District of Delaware recently denied Novartis’s request for a preliminary injunction against MSN Pharmaceuticals. Novartis Pharm. Corp. v. MSN Pharm. Inc. , Civil Action No.…
As the pharmaceutical industry continues to face an ever-changing legal environment, staying informed about trends in ANDA litigation has never been more crucial. At Patexia, we are committed to providing stakeholders with the most reliable and up-to-date…
Revlimid (lenalidomide) , developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma since its FDA approval in 2005. The drug has also been at the center of complex legal…
Written by : Nicole E. Kim & Douglas B. Wentzel AMARIN PHARMA, INC. v. HIKMA PHARMACEUTICALS USA INC. Before Moore, Lourie , and Albright. Appeal from the United States District Court for the District of Delaware. Summary : The totality of the…
Written by : Rhett D. Ramsey & Daniel Kiang JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. Before Prost , Dyk, and Hughes. Appeal from the United States District Court for the District of New Jersey. Summary : District court erred by…
Written by : Zachary B. Messick & Jacob R. Rosenbaum SALIX PHARMACEUTICALS, LTD. v. NORWICH PHARMACEUTICALS., INC. Before Lourie , Chen, and Cunningham. Appeal from the District of Delaware Summary : The Federal Circuit ruled that an ANDA listing an…
Written by : Raymond S. Lu & Brandon G. Smith PFIZER INC. v. SANOFI PASTEUR INC. Before Lourie , Bryson, and Stark. Appeal from the Patent Trial and Appeal Board. Summary : Evidence that a claimed parameter is recognized as a result-effective variable can…
As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent entry of generic or biosimilar competition. This reality underscores the imperative for continual…
Shares of UroGen Pharma (NASDAQ: URGN) took a minor premarket hit following news that Teva Pharmaceutical (NYSE: TEVA) has submitted an application seeking FDA approval for a generic version of UroGen's bladder cancer therapy, Jelmyto. The move by Teva…
Corcept Therapeutics experienced a significant drop in its stock value by 27% on Tuesday following an unfavorable verdict in a patent infringement lawsuit against Teva Pharmaceutical Industries (NASDAQ:TEVA). The ruling by a US District Court stated that…
